Protein-losing enteropathy associated with systemic lupus erythematosus: response to cyclophosphamide

Rheumatol Int. 2005 Mar;25(2):135-8. doi: 10.1007/s00296-004-0483-8. Epub 2004 Jul 13.

Abstract

Protein-losing enteropathy is a rare manifestation of systemic lupus erythematosus (SLE) leading to hypoalbuminemia and anasarca. We report the case of a woman with SLE who presented chronic hypoalbuminemia diagnosed as protein-losing enteropathy associated with SLE. She was refractory to prednisone and azathioprine administration but showed good response to cyclophosphamide. The diagnosis and management of hypoalbuminemia in lupus-associated enteropathy are discussed.

MeSH terms

  • Adult
  • Cyclophosphamide / therapeutic use*
  • Edema / etiology
  • Female
  • Humans
  • Hypoalbuminemia / etiology
  • Immunosuppressive Agents / therapeutic use*
  • Lupus Erythematosus, Systemic / complications*
  • Lupus Erythematosus, Systemic / drug therapy
  • Protein-Losing Enteropathies / drug therapy*
  • Protein-Losing Enteropathies / etiology
  • Remission Induction

Substances

  • Immunosuppressive Agents
  • Cyclophosphamide